Journal of Clinical Microbiology · 2017 · 54 citations · 11 references
Life SciencesMicrobiologyDiagnostic MicrobiologyMass Spectrometric AnalysisMedical MicrobiologyAntimicrobial Susceptibility TestingMass SpectrometryPathogen DetectionClinical Laboratory AutomationLaboratory Automation In MicrobiologyMaldi-tof IdentificationMaldi-tof Mass SpectrometryMatrix-assisted Laser Desorption Ionization Time-of-flight Mass SpectrometryMatrix-assisted Laser Desorption/ionizationMatrix-assisted Laser Desorption/ionization Time-of-flight Mass SpectrometryTime-of-flight Mass Spectrometry
ABSTRACT Technological advances have changed the practice of clinical microbiology. We implemented Bruker matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) and BD Kiestra total laboratory automation (TLA) 4 and 3 years ago, respectively. To assess the impact of these new technologies, we compared turnaround times (TATs) for positive and negative urine cultures before and after implementation. In comparison I, TATs for 61,157 urine cultures were extracted for two periods corresponding to pre-TLA and post-TLA, both using MALDI-TOF MS for organism identification. In comparison II, time to organism identification (ID) and antimicrobial susceptibility (AST) reports were calculated for 5,402 positive culture reports representing four different periods: (i) manual plating and conventional biochemical identification (CONV), (ii) manual plating and MALDI-TOF MS identification (MALDI), (iii) MALDI-TOF MS identification and early phase implementation of TLA (TLA1), and (iv) MALDI-TOF MS identification and late phase implementation of TLA (TLA2). By the comparison I results, median pre- and post-TLA TATs to organism IDs (18.5 to 16.9 h), AST results (41.8 to 40.8 h), and preliminary results for negative cultures (17.7 to 13.6 h), including interquartile ranges for all comparisons, were significantly decreased post-TLA ( P < 0.001). By the comparison II results, MALDI significantly improved TAT to organism ID compared to CONV (21.3 to 18 h). TLA further improved overall TAT to ID (18 to 16.5 h) and AST (42.3 to 40.7 h) results compared to MALDI ( P < 0.001). In summary, TLA significantly improved TAT to organism ID, AST report, and preliminary negative results. MALDI-TOF MS significantly improved TAT for organism ID. Use of MALDI-TOF MS and TLA individually and together results in significant decreases in microbiology report TATs.
11
Piseth Seng, Michel Drancourt, Frédérique Gouriet et al. · Clinical Infectious Diseases · 2009 · 1.9K citations
Tamar Walker, Sandrea Dumadag, Christine Jiyoun Lee et al. · Journal of Clinical Microbiology · 2016 · 135 citations · Full text
Alexia Verroken, L. Defourny, Olivier le Polain de Waroux et al. · PLoS ONE · 2016 · 98 citations · Full text